-
1
-
-
0037345718
-
Towards a consensus in symptomatic gastroesophageal reflux disease: Introduction
-
DOI 10.1016/S0002-9270(03)00008-X
-
Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003 98 : S2 7. (Pubitemid 36348508)
-
(2003)
American Journal of Gastroenterology
, vol.98
, Issue.3 SUPPL.
-
-
Fass, R.1
-
2
-
-
0037345566
-
Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients
-
Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003 98 : S31 9.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 31-9
-
-
Bytzer, P.1
-
3
-
-
33750136298
-
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
-
van Pinxteren B, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2006 3 : CD002095.
-
(2006)
Cochrane Database Syst Rev
, vol.3
-
-
Van Pinxteren, B.1
Numans, M.E.2
Bonis, P.A.3
Lau, J.4
-
4
-
-
0036677469
-
Gastroesophageal reflux disease - Should we adopt a new conceptual framework?
-
Fass R, Ofman JJ. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002 97 : 1901 1909.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 1901-1909
-
-
Fass, R.1
Ofman, J.J.2
-
5
-
-
9344221689
-
Reflux symptom relief with omeprazole in patients without unequivocal esophagitis
-
Bate CM, Griffin SM, Keeling PW, et al. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996 10 : 547 555. (Pubitemid 26254798)
-
(1996)
Alimentary Pharmacology and Therapeutics
, vol.10
, Issue.4
, pp. 547-555
-
-
Bate, C.M.1
Griffin, S.M.2
Keeling, P.W.N.3
Axon, A.T.R.4
Dronfield, M.W.5
Chapman, R.W.G.6
O'Donoghue, D.7
Calam, J.8
Crower, J.9
Mountford, R.A.10
Watts, D.A.11
Taylor, M.D.12
Richardson, P.D.I.13
-
6
-
-
15444356140
-
Heartburn without oesophagitis: Efficacy of omeprazole therapy and features determining therapeutic response
-
Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997 32 : 974 979. (Pubitemid 27433659)
-
(1997)
Scandinavian Journal of Gastroenterology
, vol.32
, Issue.10
, pp. 974-979
-
-
Lind, T.1
Havelund, T.2
Carlsson, R.3
Anker-Hansen, O.4
Glise, H.5
Hernqvist, H.6
Junghard, O.7
Lauritsen, K.8
Lundell, L.9
Pedersen, S.-A.10
Stubberod, A.11
-
7
-
-
27144502406
-
Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease
-
DOI 10.1007/s10620-005-3000-3
-
Kahrilas PJ, Miner P, Johanson J, Mao L, Jokubaitis L, Sloan S. Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease. Dig Dis Sci 2005 50 : 2009 2018. (Pubitemid 41504082)
-
(2005)
Digestive Diseases and Sciences
, vol.50
, Issue.11
, pp. 2009-2018
-
-
Kahrilas, P.J.1
Miner, P.2
Johanson, J.3
Mao, L.4
Jokubaitis, L.5
Sloan, S.6
-
8
-
-
0037343926
-
Diagnosis of symptomatic gastroesophageal reflux disease
-
Kahrilas PJ. Diagnosis of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003 98 : S15 23.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 15-23
-
-
Kahrilas, P.J.1
-
9
-
-
19244380563
-
Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole
-
Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998 10 : 119 124. (Pubitemid 28101879)
-
(1998)
European Journal of Gastroenterology and Hepatology
, vol.10
, Issue.2
, pp. 119-124
-
-
Carlsson, R.1
Dent, J.2
Watts, R.3
Riley, S.4
Sheikh, R.5
Hatlebakk, J.6
Haug, K.7
De Groot, G.8
Van Oudvorst, A.9
Dalvag, A.10
Junghard, O.11
Wiklund, I.12
-
10
-
-
0033011401
-
Factors influencing compliance in long-term proton pump inhibitor therapy in general practice
-
Hungin AP, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999 49 : 463 464. (Pubitemid 29304147)
-
(1999)
British Journal of General Practice
, vol.49
, Issue.443
, pp. 463-464
-
-
Hungin, A.P.S.1
Rubin, G.2
O'Flanagan, H.3
-
11
-
-
20444455328
-
2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients
-
DOI 10.1111/j.1365-2036.2005.02490.x
-
Zacny J, Zamakhshary M, Sketris I, Veldhuyzen van Zanten S. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther 2005 21 : 1299 1312. (Pubitemid 40813676)
-
(2005)
Alimentary Pharmacology and Therapeutics
, vol.21
, Issue.11
, pp. 1299-1312
-
-
Zacny, J.1
Zamakhshary, M.2
Sketris, I.3
Van Zanten, S.V.4
-
12
-
-
0033034891
-
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - A placebo-controlled randomized trial
-
DOI 10.1046/j.1365-2036.1999.00564.x
-
Lind T, Havelund T, Lundell L, et al. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999 13 : 907 914. (Pubitemid 29312776)
-
(1999)
Alimentary Pharmacology and Therapeutics
, vol.13
, Issue.7
, pp. 907-914
-
-
Lind, T.1
Havelund, T.2
Lundell, L.3
Glise, H.4
Lauritsen, K.5
Pedersen, S.A.6
Anker-Hansen, O.7
Stubberod, A.8
Eriksson, G.9
Carlsson, R.10
Junghard, O.11
-
13
-
-
0035114856
-
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: A controlled trial of 'on-demand' therapy for 6 months
-
DOI 10.1046/j.1365-2036.2001.00943.x
-
Talley NJ, Lauritsen K, Tunturi-Hihnala H, et al. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther 2001 15 : 347 354. (Pubitemid 32187556)
-
(2001)
Alimentary Pharmacology and Therapeutics
, vol.15
, Issue.3
, pp. 347-354
-
-
Talley, N.J.1
Lauritsen, K.2
Tunturi-Hihnala, H.3
Lind, T.4
Moum, B.5
Bang, C.6
Schulz, T.7
Omland, T.M.8
Delle, M.9
Junghard, O.10
-
14
-
-
0036667969
-
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: A placebo-controlled trial of on-demand therapy for 6 months
-
Talley NJ, Venables TL, Green JR, et al. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol 2002 14 : 857 863.
-
(2002)
Eur J Gastroenterol Hepatol
, vol.14
, pp. 857-863
-
-
Talley, N.J.1
Venables, T.L.2
Green, J.R.3
-
15
-
-
24944540256
-
On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: The ORION trial
-
DOI 10.1159/000087661
-
Scholten T, Dekkers CP, Schutze K, Korner T, Bohuschke M, Gatz G. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. Digestion. 2005 72 : 76 85. (Pubitemid 41507266)
-
(2005)
Digestion
, vol.72
, Issue.2-3
, pp. 76-85
-
-
Scholten, T.1
Dekkers, C.P.M.2
Schutze, K.3
Korner, T.4
Bohuschke, M.5
Gatz, G.6
-
16
-
-
23944433411
-
Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease
-
DOI 10.1097/00042737-200509000-00009
-
Kaspari S, Kupcinskas L, Heinze H, Berghofer P. Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2005 17 : 935 941. (Pubitemid 41192132)
-
(2005)
European Journal of Gastroenterology and Hepatology
, vol.17
, Issue.9
, pp. 935-941
-
-
Kaspari, S.1
Kupcinskas, L.2
Heinze, H.3
Berghofer, P.4
-
17
-
-
1542277920
-
Efficacy of lansoprazole on demand therapy in the treatment of non-erosive reflux disease and functional ulcer-like dyspepsia
-
Cooper A, Baxter G. Efficacy of lansoprazole on demand therapy in the treatment of non-erosive reflux disease and functional ulcer-like dyspepsia. Gut 2003 52 : A137.
-
(2003)
Gut
, vol.52
, pp. 137
-
-
Cooper, A.1
Baxter, G.2
-
18
-
-
3242890564
-
Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease
-
DOI 10.1111/j.1365-2036.2004.01999.x
-
Bytzer P, Blum A, De Herdt D, Dubois D. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2004 20 : 181 188. (Pubitemid 38998216)
-
(2004)
Alimentary Pharmacology and Therapeutics
, vol.20
, Issue.2
, pp. 181-188
-
-
Bytzer, P.1
Blum, A.2
De Herdt, D.3
Dubois, D.4
-
19
-
-
3543002869
-
On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: Effectiveness, health-related quality of life, and patient satisfaction
-
DOI 10.1023/B:DDAS.0000034551.39324.c3
-
Ponce J, Arguello L, Bastida G, Ponce M, Ortiz V, Garrigues V. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. Dig Dis Sci 2004 49 : 931 936. (Pubitemid 39012275)
-
(2004)
Digestive Diseases and Sciences
, vol.49
, Issue.6
, pp. 931-936
-
-
Ponce, J.1
Arguello, L.2
Bastida, G.3
Ponce, M.4
Ortiz, V.5
Garrigues, V.6
-
20
-
-
16444386234
-
Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: On-demand treatment compared with continuous treatment
-
DOI 10.1111/j.1365-2036.2005.02413.x
-
Bour B, Staub JL, Chousterman M, et al. Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment. Aliment Pharmacol Ther 2005 21 : 805 812. (Pubitemid 40477240)
-
(2005)
Alimentary Pharmacology and Therapeutics
, vol.21
, Issue.7
, pp. 805-812
-
-
Bour, B.1
Staub, J.-L.2
Chousterman, M.3
Labayle, D.4
Nalet, B.5
Nouel, O.6
Pariente, A.7
Tocque, E.8
Bonnot-Marlier, S.9
-
21
-
-
0033585865
-
Symptomatic gastro-oesophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine
-
Bardhan KD, Muller-Lissner S, Bigard MA, et al. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. BMJ 1999 318 : 502 507. (Pubitemid 29188994)
-
(1999)
British Medical Journal
, vol.318
, Issue.7182
, pp. 502-507
-
-
Bardhan, K.D.1
Muller-Lissner, S.2
Bigard, M.A.3
Bianchi Porro, G.4
Ponce, J.5
Hosie, J.6
Scott, M.7
Weir, D.G.8
Gillon, K.R.W.9
Peacock, R.A.10
Fulton, C.11
-
23
-
-
27744532756
-
Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease
-
DOI 10.2165/00019053-200523100-00006
-
Hughes DA, Bodger K, Bytzer P, De Herdt D, Dubois D. Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease. Pharmacoeconomics. 2005 23 : 1031 1041. (Pubitemid 41603436)
-
(2005)
PharmacoEconomics
, vol.23
, Issue.10
, pp. 1031-1041
-
-
Hughes, D.A.1
Bodger, K.2
Bytzer, P.3
De Herdt, D.4
Dubois, D.5
|